Richard I. Lindley

Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial

Geoffrey A. Donnan, Leonid Churilov, Peter Langhorne, 2015, The Lancet.

Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial

Joanna M. Wardlaw, Eleni Sakka, Geoff Cohen, 2015, The Lancet Neurology.

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

Peter Sandercock, Joanna Wardlaw, G Middleton, 1997, The Lancet.

Cost-Effectiveness of Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Assessed by a Model Based on UK NHS Costs

Joanna M. Wardlaw, Peter Sandercock, Joseph Kwan, 2004, Stroke.

Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke Trial

Joanna M. Wardlaw, Eleni Sakka, Geoff Cohen, 2015, Stroke.